Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Scientists at École Polytechnique Fédérale Lausanne (EPFL), and at UNIL-CHUV, University Hospital Lausanne (CHUV) and University of Lausanne (UNIL) have developed a computational method to create ...

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in ...

Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells. Using molecules known as AbLecs, which consist of a lectin attached to a tumor ...

Recently these monocyte-derived alveolar macrophages, or Mo-AMs, were identified as key drivers of lung fibrosis disease progression. However, the mechanisms of their pro-fibrotic behavior and ...

Scientists showed that using new molecules that block an immune "checkpoint" could stimulate a "strong" anti-tumor immune ...